Deepak Chemtex's FY26 Performance Shows Revenue and Profit Decline

Deepak Chemtex Limited's standalone revenue from operations for the year ended March 31, 2026, fell by 21.32% to ₹53.50 crore, down from ₹68.00 crore in FY 2025. Standalone profit after tax also decreased by 34.52% to ₹6.59 crore. Basic Earnings Per Share (EPS) declined to ₹5.97 from ₹9.27.

On a consolidated basis, revenue from operations contracted by 14.86% to ₹67.64 crore in FY 2026 from ₹79.45 crore in FY 2025. Consolidated profit for the period saw a 32.30% drop to ₹8.47 crore, with basic EPS falling to ₹7.80 from ₹11.69.

Reader Takeaway: Declining revenues and profits are a concern, but an unmodified audit opinion offers some reassurance.

What just happened

Deepak Chemtex Limited announced its audited financial results for the fiscal year ended March 31, 2026. The company reported a significant year-over-year decrease in both standalone and consolidated revenue and profit. This marks a contraction in the company's financial performance.

Why this matters

The decline in revenue and profit indicates reduced operational performance and profitability for the fiscal year. For shareholders, this signals a challenging period for the company and raises questions about future growth prospects and the ability to recover lost ground.

The backstory

Deepak Chemtex Limited is a single-segment operational company. The company's board meeting to approve these financial results was held on May 29, 2026. The financial statements reflect the performance over the entire fiscal year.

What changes now

Investors will be looking for strategies and initiatives from the management to reverse the current downward trend. The company's operational focus remains on its single segment, and its ability to adapt and grow within this segment will be critical.

Risks to watch

A key watch point is the company's reliance on third-party audit reports for its foreign subsidiaries. While the auditors issued an unmodified opinion, the portion of consolidated financials relying on external reports could present a subtle risk if those audits had differing outcomes.

Auditor Remarks

The statutory auditors, Mittal & Associates, provided an unmodified opinion on the financial results. However, they noted that they did not audit the financial statements of foreign subsidiaries, whose total assets were ₹8.44 crore and total revenue was ₹13.90 crore before consolidation. The auditors relied on reports from other auditors for these entities.

Regulatory Updates

Deepak Chemtex has assessed the impact of the four Labour Codes notified in November 2025. Management stated that these regulatory changes currently have no material financial impact on the company. They are continuing to monitor for further clarifications.

Context metrics (time-bound)

• Standalone Revenue: ₹53.50 crore (FY 2026) vs ₹68.00 crore (FY 2025) - a 21.32% decrease.
• Standalone Profit: ₹6.59 crore (FY 2026) vs ₹10.07 crore (FY 2025) - a 34.52% decrease.
• Consolidated Revenue: ₹67.64 crore (FY 2026) vs ₹79.45 crore (FY 2025) - a 14.86% decrease.
• Consolidated Profit: ₹8.47 crore (FY 2026) vs ₹12.51 crore (FY 2025) - a 32.30% decrease.

What to track next

Investors should closely track the company's revenue and profit trends in the upcoming quarters to see if the current decline is a temporary setback or a sustained trend. Management commentary on future strategies for growth and profitability will be crucial.